Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

The predictive value of C-reactive protein on recurrence of atrial fibrillation after cardioversion with or without treatment with atorvastatin.

Höglund N, Andersson J, Almroth H, Tornvall P, Englund A, Rosenqvist M, Jensen SM, Boman K.

Int J Cardiol. 2013 Sep 1;167(5):2088-91. doi: 10.1016/j.ijcard.2012.05.071. Epub 2012 Jun 15.

PMID:
22704860
[PubMed - indexed for MEDLINE]
2.

Statin therapy for the prevention of atrial fibrillation trial (SToP AF trial).

Negi S, Shukrullah I, Veledar E, Bloom HL, Jones DP, Dudley SC.

J Cardiovasc Electrophysiol. 2011 Apr;22(4):414-9. doi: 10.1111/j.1540-8167.2010.01925.x. Epub 2010 Oct 13.

PMID:
20946227
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Comparison of atorvastatin and simvastatin in prevention of atrial fibrillation after successful cardioversion.

Naji F, Suran D, Kanic V, Vokac D, Sabovic M.

Int Heart J. 2009 Mar;50(2):153-60.

PMID:
19367026
[PubMed - indexed for MEDLINE]
Free Article
4.

The effect of sinus rhythm restoration on high-sensitivity C-reactive protein levels and their association with long-term atrial fibrillation recurrence after electrical cardioversion.

Celebi OO, Celebi S, Canbay A, Ergun G, Aydogdu S, Diker E.

Cardiology. 2011;118(3):168-74. doi: 10.1159/000327998. Epub 2011 Jun 3.

PMID:
21654170
[PubMed - indexed for MEDLINE]
5.

Effect of atorvastatin on the recurrence rates of atrial fibrillation after electrical cardioversion.

Ozaydin M, Varol E, Aslan SM, Kucuktepe Z, Dogan A, Ozturk M, Altinbas A.

Am J Cardiol. 2006 May 15;97(10):1490-3. Epub 2006 Mar 29.

PMID:
16679090
[PubMed - indexed for MEDLINE]
6.

Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study.

Almroth H, Höglund N, Boman K, Englund A, Jensen S, Kjellman B, Tornvall P, Rosenqvist M.

Eur Heart J. 2009 Apr;30(7):827-33. doi: 10.1093/eurheartj/ehp006. Epub 2009 Feb 6.

PMID:
19202157
[PubMed - indexed for MEDLINE]
Free Article
7.

Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion.

Loricchio ML, Cianfrocca C, Pasceri V, Bianconi L, Auriti A, Calo L, Lamberti F, Castro A, Pandozi C, Palamara A, Santini M.

Am J Cardiol. 2007 May 15;99(10):1421-4. Epub 2007 Apr 5.

PMID:
17493472
[PubMed - indexed for MEDLINE]
8.

Markers of fibrinolysis as predictors for maintenance of sinus rhythm after electrical cardioversion.

Andersson J, Almroth H, Höglund N, Jensen S, Tornvall P, Englund A, Rosenqvist M, Boman K.

Thromb Res. 2011 Mar;127(3):189-92. doi: 10.1016/j.thromres.2010.06.002. Epub 2011 Jan 14.

PMID:
21237502
[PubMed - indexed for MEDLINE]
9.

High sensitivity C-reactive protein: a novel predictor for recurrence of atrial fibrillation after successful cardioversion.

Malouf JF, Kanagala R, Al Atawi FO, Rosales AG, Davison DE, Murali NS, Tsang TS, Chandrasekaran K, Ammash NM, Friedman PA, Somers VK.

J Am Coll Cardiol. 2005 Oct 4;46(7):1284-7.

PMID:
16198844
[PubMed - indexed for MEDLINE]
Free Article
10.

Atorvastatin for prevention of atrial fibrillation recurrence following pulmonary vein isolation: a double-blind, placebo-controlled, randomized trial.

Suleiman M, Koestler C, Lerman A, Lopez-Jimenez F, Herges R, Hodge D, Bradley D, Cha YM, Brady PA, Munger TM, Asirvatham SJ, Packer DL, Friedman PA.

Heart Rhythm. 2012 Feb;9(2):172-8. doi: 10.1016/j.hrthm.2011.09.016. Epub 2011 Sep 13.

PMID:
21920481
[PubMed - indexed for MEDLINE]
11.

Atorvastatin given prior to electrical cardioversion does not affect the recurrence of atrial fibrillation in patients with persistent atrial fibrillation who are on antiarrhythmic therapy.

Demir K, Can I, Koc F, Vatankulu MA, Ayhan S, Akilli H, Aribas A, Alihanoglu Y, Altunkeser BB.

Med Princ Pract. 2011;20(5):464-9. doi: 10.1159/000327674. Epub 2011 Jul 11.

PMID:
21757938
[PubMed - indexed for MEDLINE]
12.

Serum amyloid a and C-reactive protein independently predict the recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function.

Barassi A, Pezzilli R, Morselli-Labate AM, Lombardi F, Belletti S, Dogliotti G, Corsi MM, Merlini G, Melzi d'Eril GV.

Can J Cardiol. 2012 Sep-Oct;28(5):537-41. doi: 10.1016/j.cjca.2012.02.014. Epub 2012 May 1.

PMID:
22552174
[PubMed - indexed for MEDLINE]
13.

High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion.

Watanabe E, Arakawa T, Uchiyama T, Kodama I, Hishida H.

Int J Cardiol. 2006 Apr 14;108(3):346-53. Epub 2005 Jun 17.

PMID:
15964643
[PubMed - indexed for MEDLINE]
14.

Evaluation of C-reactive protein prior to and on-treatment as a predictor of benefit from atorvastatin: observations from the Anglo-Scandinavian Cardiac Outcomes Trial.

Sever PS, Poulter NR, Chang CL, Hingorani A, Thom SA, Hughes AD, Welsh P, Sattar N; ASCOT Investigators.

Eur Heart J. 2012 Feb;33(4):486-94. doi: 10.1093/eurheartj/ehr262. Epub 2011 Jul 28.

PMID:
21798891
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The effects of atorvastatin on the occurrence of postoperative atrial fibrillation after off-pump coronary artery bypass grafting surgery.

Song YB, On YK, Kim JH, Shin DH, Kim JS, Sung J, Lee SH, Kim WS, Lee YT.

Am Heart J. 2008 Aug;156(2):373.e9-16. doi: 10.1016/j.ahj.2008.04.020. Epub 2008 Jun 17.

PMID:
18657672
[PubMed - indexed for MEDLINE]
16.

Predictors for maintenance of sinus rhythm after cardioversion in patients with nonvalvular atrial fibrillation.

Okçün B, Yigit Z, Küçükoglu MS, Mutlu H, Sansoy V, Güzelsoy D, Uner S.

Echocardiography. 2002 Jul;19(5):351-7.

PMID:
12174197
[PubMed - indexed for MEDLINE]
17.

Prognostic impact of hs-CRP and IL-6 in patients with persistent atrial fibrillation treated with electrical cardioversion.

Henningsen KM, Therkelsen SK, Bruunsgaard H, Krabbe KS, Pedersen BK, Svendsen JH.

Scand J Clin Lab Invest. 2009;69(3):425-32. doi: 10.1080/00365510802676848.

PMID:
19204850
[PubMed - indexed for MEDLINE]
18.

The predictive value of plasma brain natriuretic peptide for the recurrence of atrial fibrillation six months after external cardioversion.

Ari H, Binici S, Ari S, Akkaya M, Koca V, Bozat T, Gürdoğan M.

Turk Kardiyol Dern Ars. 2008 Oct;36(7):456-60.

PMID:
19155659
[PubMed - indexed for MEDLINE]
19.

Hypertension and paroxysmal atrial fibrillation: a novel predictive role of high sensitivity C-reactive protein in cardioversion and long-term recurrence.

Rizos I, Rigopoulos AG, Kalogeropoulos AS, Tsiodras S, Dragomanovits S, Sakadakis EA, Faviou E, Kremastinos DT.

J Hum Hypertens. 2010 Jul;24(7):447-57. doi: 10.1038/jhh.2009.89. Epub 2010 Jan 14.

PMID:
20072146
[PubMed - indexed for MEDLINE]
20.

Effect of candesartan and various inflammatory markers on maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation.

Tveit A, Seljeflot I, Grundvold I, Abdelnoor M, Smith P, Arnesen H.

Am J Cardiol. 2007 Jun 1;99(11):1544-8. Epub 2007 Apr 16.

PMID:
17531578
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk